Delfi Diagnostics

Early cancer detection could save millions of lives and billions of dollars a year. Recent advances in the understanding of cancer DNA and machine learning allow Delfi to dramatically reduce the cost of screening tests while increasing performance. The company takes a more holistic, genome-based approach to detecting early stage cancer sooner through a non-invasive screening solution.